Breakthrough in Biotech: CAR T-Cell Therapy Expands to Autoimmune Diseases
CAR T-cell therapy is moving beyond oncology; new research shows its breakthrough potential in resetting immune systems to treat stubborn autoimmune diseases like lupus.
CAR T-cell therapy is moving beyond oncology; new research shows its breakthrough potential in resetting immune systems to treat stubborn autoimmune diseases like lupus.
CAR T-cell therapy is expanding from oncology to autoimmune disease treatment; PubMed studies confirm its potential to reset the immune system, offering new hope for conditions like lupus.
CAR T-cell therapy is expanding beyond cancer treatment, showing significant potential as a revolutionary approach to autoimmune diseases. Recent studies demonstrate its ability to 'reset' the immune system by selectively eliminating disease-driving cells. This breakthrough marks a transition for cell therapy from a single-use cancer tool to a flexible, programmable platform for immune remodeling.